State of New Jersey Common Pension Fund D’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Buy
15,523
+4,970
+47% +$93.9K ﹤0.01% 1658
2026
Q1
$174K Buy
+10,553
New +$202K ﹤0.01% 1536

Other funds holding GLUE

State of New Jersey Common Pension Fund D's GLUE Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D increased its Monte Rosa Therapeutics (GLUE) stake by 47% in Q2 2026, buying an estimated $93.9K and bringing the position to 15,523 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #1658.

State of New Jersey Common Pension Fund D first reported a position in GLUE in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 15,523 shares of Monte Rosa Therapeutics worth $376K as of Q2 2026.
  • State of New Jersey Common Pension Fund D bought 4,970 Monte Rosa Therapeutics shares in Q2 2026, an estimated $93.9K.
  • Monte Rosa Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1658 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Monte Rosa Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.